Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yi-Liang Lu"'
Autor:
Yi-Liang Lu, 盧宜良
100
This thesis constructs a desktop virtual reality system by using MATLAB handle graphics to simulate a micromouse to solve a maze. The desktop virtual reality platform enables the beginners to perform their micromouse decision programs faster
This thesis constructs a desktop virtual reality system by using MATLAB handle graphics to simulate a micromouse to solve a maze. The desktop virtual reality platform enables the beginners to perform their micromouse decision programs faster
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/01925198741342419648
Autor:
Yi-Liang Lu, 呂怡樑
88
The early information transmission mediums depend on mainly paper documents. Although the paper document is inconvenient in the maintenance, it has brought about interactive electronic technical manual's(IETM) concepts to come with the tide o
The early information transmission mediums depend on mainly paper documents. Although the paper document is inconvenient in the maintenance, it has brought about interactive electronic technical manual's(IETM) concepts to come with the tide o
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/26928368007415660471
Autor:
Zi-Xuan Hong, Ling-Huei Yih, Yi-Ting Chia, Shih-Ting Chang, Yi-Liang Lu, Kuo-Chu Lai, Tai-Lin Chen, Mann-Jen Hour
Publikováno v:
Anticancer research. 41(1)
Background/aim Quinazolinone is a privileged chemical structure employed for targeting various types of cancer. This study aimed to demonstrate the antitumor activity of synthesized 6,7-disubstituted-2-(3-fluorophenyl) quinazolines (HoLu-11 to HoLu-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a884733b2c6a9a9c26ed7b4503a7220c
https://pubmed.ncbi.nlm.nih.gov/33419820
https://pubmed.ncbi.nlm.nih.gov/33419820
Autor:
Yi-Liang Lu, Po Wu Gean, Mann-Jen Hour, Ching Chen, Kuo Hsiung Lee, I-Chen Lu, Sheng-Chu Kuo, Ta-Shu Song, Tai-Lin Chen, Wei-Ting Liu
Publikováno v:
Neuropharmacology. 86:219-227
Malignant gliomas are among the most devastating cancers as they are resistant to many kinds of treatment. Despite recent advances in the diagnosis and treatment, the prognosis of patients remains very poor and the development of new drug is urgently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2924fb428efdb7e95deb3288c80005a
https://doi.org/10.1016/j.neuropharm.2014.07.014
https://doi.org/10.1016/j.neuropharm.2014.07.014